Literature DB >> 4138541

New inhibitor of reagin-mediated anaphylaxis.

B J Broughton, P Chaplen, P Knowles, E Lunt, D L Pain, K R Wooldridge, R Ford, S Marshall, J L Walker, D R Maxwell.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4138541     DOI： 10.1038/251650a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Cromoglycate and other antiallergic drugs: a possible mechanism of action.

Authors:  J C Foreman; L G Garland
Journal:  Br Med J       Date:  1976-04-03

2.  Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle.

Authors:  A Bowman; A H Drummond
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

3.  The pharmacology of anaphylaxis in the chicken intestine.

Authors:  N Chand; P Eyre
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

4.  Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.

Authors:  N Frossard; Y Landry; G Pauli; M Ruckstuhl
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

5.  The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.

Authors:  M K Church; C F Gradidge
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

6.  Ro 21-7634, a new antiallergic agent with potent oral activity.

Authors:  R A Salvador; L B Czyzewski; H Baruth; A Hooper; A Medford; D Miller; T van Trabert; B Yaremko; A F Welton
Journal:  Agents Actions       Date:  1981-07

7.  The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Authors:  Ghazwan Butrous
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.